Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.

Effective July 25, 2022, and in accordance with the terms of the Acutus Medical, Inc. 2011 Equity Incentive Plan and the Acutus Medical, Inc. 2020 Equity Incentive Plan (the "Incentive Plans"), the Board of Directors (the "Board") of Acutus Medical, Inc. (the "Company") reduced the exercise price of outstanding options to purchase the Company's common stock held by employees of the Company who were employed on July 25, 2022 (and who had not provided a notice of resignation prior to such date) (the "Designated Options") to $1.34 per share, which was the closing price for the Company's common stock on July 25, 2022. The exercise price reduction includes options held by, among others, the Company's Chief Executive Officer, David Roman, with respect to 127,335 shares (with original exercise prices ranging from $2.41 to $13.66).

Except for the reduction in the exercise price of the Designated Options, all outstanding stock options continue to remain outstanding in accordance with their current terms and conditions as set forth in the Incentive Plans and award agreements thereunder.

Item 9.01. Financial Statements and Exhibits.





 (d) Exhibits



Exhibit
Number                                    Description
104       Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       2

© Edgar Online, source Glimpses